Skip to main content
Premium Trial:

Request an Annual Quote

Protein Analytics Firm BioScale Raises $25M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein analytics firm BioScale said today it has raised $25 million in a recent financing round, to be used to commercialize the company's technology.

The round was led by new investor Morningside Venture, as well as existing investors New Science Ventures, WFD Ventures, F2 Ventures, and several individual investors.

BioScale will use the funds to expand manufacturing operations and sales of its ViBE protein analytics systems, the company said in a statement.

ViBE provides highly sensitive reproducible detection and quantitation of analytes in complex biological samples, BioScale said, and allows customers to create and configure their own assays using BioScale's lead technology, called Acoustic Membrane MicroParticle, or AMMP.

AMMP is a label-free non-optical homogeneous assay that allows ultra-sensitive detection in complex matrices at the picogram level.

In a statement, Isaac Cheng of Morningside Venture said that his firm is "excited" about the therapeutic and diagnostic potential of BioScale's protein biomarkers, "and feel BioScale's next-generation proteomics platform is well-positioned to become a leader in the protein measurement space."

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.